(Q60364299)
Statements
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange (English)
0 references
February 2000
0 references
292
0 references
2
0 references
512-20
0 references